NCT Number: NCT00358280
Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery
The purpose of this study is to compare the efficacy, duration of motor block until return to normal function in the non-operated leg after the start of injection, of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml when used for spinal anaesthesia in patients undergoing unilateral lower limb surgery.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Research Site, Beijing, China
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Provision of written informed consent
- Men or women, 18 years £ age £ 70 years
- Patient scheduled for unilateral lower limb surgery with an estimated duration < 2 hours under spinal anaesthesia
- ASA category I ~ II
- 18.5 ≤ BMI ≤ 23.9
Exclusion criteria
- Contraindications to spinal anaesthesia, such as local infections, generalised septicaemia, platelet and clotting factor abnormalities, significant neurological disease with motor or sensory deficit, diagnosed increased intracranial pressure
- A known history of allergy, sensitivity or any other form of reaction to local anaesthetics of amide type
- Suspected inability to comply with the study procedures, including language difficulties or medical history and/or concomitant disease, as judged by the investigator
- Psychiatric history or any other concomitant disease which may lead to unreliability in clinical assessments, as judged by the investigator
- Significant alcohol, drug or medication abuse, as judged by the investigator
- Women who are pregnant or lactating or women of child bearing potential who are not practising adequate contraception or have positive urine pregnancy test (a urine Human chorionic gonadotropin [HCG] analysis)
- Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site)
- Previous enrolment in the present study
- Participation in a clinical study during the last 3 months
- Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subjects' safety or successful participation in the study.
Treatment and study plan
Bupivacaine
DrugPrimary outcomes
-
To compare the efficacy, duration of motor block until return to normal function in the non-operated leg after the start of injection, of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml when used for spinal anaesthesia in patients undergoing unilateral lower
Secondary outcomes
-
To compare the efficacy of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml in the duration of sensory block at dermatome T10 level
-
To compare the efficacy of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml in the onset time of sensory block and motor block respectively
-
To compare the efficacy of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml in the quality of anaesthesia
-
To compare the efficacy of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml in subject pain during surgery
-
To determine the safety of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml by evaluating the incidence and severity of adverse events, blood pressure, pulse rate and blood loss
Sponsors and collaborators
Lead sponsor
AstraZeneca
Industry
Registry information
Official study title
A Randomised, Double-Blind, Multi-Centre, Parallel Group Study Comparing Efficacy and Safety of 5 mg/ml Ropivacaine and 5 mg/ml Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery
Important dates
- Study start
- 2006
- Study completion
- 2006
- First posted
- Jul 31, 2006
- Registry last updated
- Mar 26, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Different Approaches to Maternal Hypotension During Cesarean Section
NCT00991627
Anesthesia,Spinal, Cardiovascular Diseases
Parma, PR, Italy
View Trial DetailsAtropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section
NCT00921102
Anesthesia,Spinal, Cesarean Section
Messina, ME, Italy
View Trial DetailsEffect of Anesthesia Techniques on Quality of Recovery Scores in HOLEP Surgery
NCT07020390
Anesthesia, General, Anesthesia,Spinal
Melikgazi, Kayseri, Turkey (Türkiye)
View Trial DetailsAnesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial
NCT06982690
Anesthesia, General, Anesthesia,Spinal
Taipei, Taiwan
View Trial Details